Dnmt3a restrains mast cell inflammatory responses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 8, 2017, Pages E1490-E1499

  Leoni, Cristina ^a,b   Montagner, Sara ^a   Rinaldi, Andrea ^c   Bertoni, Francesco ^c,d   Polletti, Sara ^e   Balestrieri, Chiara ^e   Monticelli, Silvia ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF LUGANO   (Switzerland)

^d ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

DNA methylation; Epigenetics; Inflammation; Mast cells

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; DECITABINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GLUTATHIONE PEROXIDASE 3; IMMUNOGLOBULIN E; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR; AZACITIDINE; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE 5) METHYLTRANSFERASE 1; DNMT1 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IQGAP2 PROTEIN, MOUSE; OXAZOLONE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA METHYLATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENOTYPE; IMMUNOPRECIPITATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; NUCLEAR IMPORT; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CONTACT DERMATITIS; DEGRANULATION; DISEASE MODEL; DRUG EFFECTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MUTATION; PASSIVE SKIN ANAPHYLAXIS; PHYSIOLOGY; RNA INTERFERENCE; SYSTEMIC MASTOCYTOSIS;

ANIMALS; AZACITIDINE; CELL DEGRANULATION; CELL PROLIFERATION; CELLS, CULTURED; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; DNA (CYTOSINE-5-)-METHYLTRANSFERASES; DNA METHYLATION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIGENESIS, GENETIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOGLOBULIN E; INTERLEUKIN-3; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MICE; MICE, KNOCKOUT; MUTATION; OXAZOLONE; PASSIVE CUTANEOUS ANAPHYLAXIS; RAS GTPASE-ACTIVATING PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 85013391402     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1616420114     Document Type: Article

References (72)

1. Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25(10):1010-1022.
2. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245-254.
3. Schübeler D (2015) Function and information content of DNA methylation. Nature 517(7534):321-326.
4. Yang L, Rau R, Goodell MA (2015) DNMT3A in haematological malignancies. Nat Rev Cancer 15(3):152-165.
5. Leoni C, Vincenzetti L, Emming S, Monticelli S (2015) Epigenetics of T lymphocytes in health and disease. Swiss Med Wkly 145:14191.
6. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247-257.
7. Jeltsch A, Jurkowska RZ (2014) New concepts in DNA methylation. Trends Biochem Sci 39(7):310-318.
8. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6):915-926.
9. Tatton-Brown K, et al.; Childhood Overgrowth Consortium (2014) Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet 46(4):385-388.
10. Trowbridge JJ, Snow JW, Kim J, Orkin SH (2009) DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 5(4):442-449.
11. Tadokoro Y, Ema H, Okano M, Li E, Nakauchi H (2007) De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J Exp Med 204(4):715-722.
12. Ley TJ, et al. (2010) DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363(25):2424-2433.
13. Shlush LI, et al.; HALT Pan-Leukemia Gene Panel Consortium (2014) Identification of preleukaemic haematopoietic stem cells in acute leukaemia. Nature 506(7488):328-333.
14. Traina F, et al. (2012) Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLoS One 7(8):e43090.
15. Yang IV, et al. (2015) DNA methylation and childhood asthma in the inner city. J Allergy Clin Immunol 136(1):69-80.
16. Monticelli S, Lee DU, Nardone J, Bolton DL, Rao A (2005) Chromatin-based regulation of cytokine transcription in Th2 cells and mast cells. Int Immunol 17(11):1513-1524.
17. Haenisch B, Fröhlich H, Herms S, Molderings GJ (2014) Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease. Immunogenetics 66(5):287-297.
18. Zhang X, et al. (2016) DNMT3A and TET2 compete and cooperate to repress lineagespecific transcription factors in hematopoietic stem cells. Nat Genet 48(9):1014-1023.
19. Mayoral RJ, et al. (2011) MiR-221 influences effector functions and actin cytoskeleton in mast cells. PLoS One 6(10):e26133.
20. Demo SD, et al. (1999) Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. Cytometry 36(4):340-348.
21. Liu S, Nugroho AE, Shudou M, Maeyama K (2012) Regulation of mucosal mast cell activation by short interfering RNAs targeting syntaxin4. Immunol Cell Biol 90(3): 337-345.
22. Christman JK (2002) 5-Azacytidine and 5-Aza-2'-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy. Oncogene 21(35):5483-5495.
23. Bock C, et al. (2012) DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell 47(4):633-647.
24. Challen GA, et al. (2011) Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 44(1):23-31.
25. Tiedemann RL, et al. (2014) Acute depletion redefines the division of labor among DNA methyltransferases in methylating the human genome. Cell Reports 9(4): 1554-1566.
26. Koya J, et al. (2016) DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat Commun 7:10924.
27. Chedin F, Lieber MR, Hsieh CL (2002) The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc Natl Acad Sci USA 99(26): 16916-16921.
28. Duymich CE, Charlet J, Yang X, Jones PA, Liang G (2016) DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells. Nat Commun 7:11453.
29. Montagner S, et al. (2016) TET2 regulates mast cell differentiation and proliferation through catalytic and non-catalytic activities. Cell Reports 15(7):1566-1579.
30. Williams K, et al. (2011) TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473(7347):343-348.
31. Costa Y, et al. (2005) Two novel proteins recruited by synaptonemal complex protein 1 (SYCP1) are at the centre of meiosis. J Cell Sci 118(Pt 12):2755-2762.
32. Antonchuk J, Sauvageau G, Humphries RK (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109(1):39-45.
33. Hoser M, et al. (2008) Sox12 deletion in the mouse reveals nonreciprocal redundancy with the related Sox4 and Sox11 transcription factors. Mol Cell Biol 28(15):4675-4687.
34. Hedman AC, Smith JM, Sacks DB (2015) The biology of IQGAP proteins: Beyond the cytoskeleton. EMBO Rep 16(4):427-446.
35. Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ (2013) Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNAbinding proteins and nucleosome position. Nat Methods 10(12):1213-1218.
36. McLean CY, et al. (2010) GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28(5):495-501.
37. Sharma S, et al. (2011) Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci USA 108(28):11381-11386.
38. Willingham AT, et al. (2005) A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309(5740):1570-1573.
39. Monticelli S, Rao A (2002) NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol 32(10):2971-2978.
40. Monticelli S, Solymar DC, Rao A (2004) Role of NFAT proteins in IL13 gene transcription in mast cells. J Biol Chem 279(35):36210-36218.
41. Aramburu J, et al. (1999) Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285(5436):2129-2133.
42. Grimbaldeston MA, et al. (2005) Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167(3): 835-848.
43. Hershko AY, et al. (2011) Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity 35(4):562-571.
44. Mayle A, et al. (2015) Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood 125(4):629-638.
45. Yang L, et al. (2016) DNMT3A loss drives enhancer hypomethylation in FLT3-ITDassociated leukemias. Cancer Cell 29(6):922-934.
46. Kersh EN, et al. (2006) Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol 176(7):4083-4093.
47. Makar KW, et al. (2003) Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 4(12):1183-1190.
48. Bruniquel D, Schwartz RH (2003) Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4(3):235-240.
49. Gamper CJ, Agoston AT, Nelson WG, Powell JD (2009) Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J Immunol 183(4):2267-2276.
50. Lee PP, et al. (2001) A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15(5):763-774.
51. Yu Q, et al. (2012) DNA methyltransferase 3a limits the expression of interleukin-13 in T helper 2 cells and allergic airway inflammation. Proc Natl Acad Sci USA 109(2): 541-546.
52. Macneil LT, Walhout AJ (2011) Gene regulatory networks and the role of robustness and stochasticity in the control of gene expression. Genome Res 21(5):645-657.
53. Garzon R, et al. (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113(25):6411-6418.
54. Wang Q, et al. (2015) Down-regulation of microRNA-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast cells. PLoS One 10(4):e0123575.
55. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1): 6-21.
56. Monticelli S, Natoli G (2013) Short-Term memory of danger signals and environmental stimuli in immune cells. Nat Immunol 14(8):777-784.
57. Skarnes WC, et al. (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474(7351):337-342.
58. Mayoral RJ, Monticelli S (2010) Stable overexpression of miRNAs in bone marrowderived murine mast cells using lentiviral expression vectors. Methods Mol Biol 667: 205-214.
59. Deho' L, et al. (2014) Two functionally distinct subsets of mast cells discriminated by IL-2-independent CD25 activities. J Immunol 193(5):2196-2206.
60. Rusca N, et al. (2012) MiR-146a and NF-κB1 regulate mast cell survival and T lymphocyte differentiation. Mol Cell Biol 32(21):4432-4444.
61. Schepers E, Glorieux G, Dhondt A, Leybaert L, Vanholder R (2009) Flow cytometric calcium flux assay: Evaluation of cytoplasmic calcium kinetics in whole blood leukocytes. J Immunol Methods 348(1-2):74-82.
62. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408.
63. Lara-Astiaso D, et al. (2014) Immunogenetics. Chromatin state dynamics during blood formation. Science 345(6199):943-949.
64. Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30(15):2114-2120.
65. Langmead B, Salzberg SL (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9(4):357-359.
66. Li H, et al.; 1000 Genome Project Data Processing Subgroup (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25(16):2078-2079.
67. Zhang Y, et al. (2008) Model-based analysis of ChIP-seq (MACS). Genome Biol 9(9): R137.
68. Quinlan AR, Hall IM (2010) BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 26(6):841-842.
69. Heinz S, et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38(4):576-589.
70. Harrow J, et al. (2012) GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res 22(9):1760-1774.
71. Fujita PA, et al. (2011) The UCSC Genome Browser database: Update 2011. Nucleic Acids Res 39(Database issue):D876-D882.
72. Leoni C, et al. (2015) Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis. Eur J Haematol 95(6):566-575.